Alerts
Holiday Hours Information

In recognition of the Christmas and New Year’s holidays, some of The University of Kansas Cancer Center’s offices will have modified hours on Wednesday, December 25, and Wednesday, January 1.

More info
Skip Navigation
Back to search results

A Prospective, Non-Interventional Study to Assess the Prevalence of PD-L1 Expression in the First-Line Setting of Locally Advanced/Unresectable or Metastatic Urothelial Carcinoma

Brief Summary

Type:
Bladder

Study Type:
Diagnostic

Phase:
N/A

ClinicalTrials.gov Identifier:
NCT03788746

Study #:
STUDY00144044

Start Date:
Apr 14, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03788746

View Complete Trial Details & Eligibility at ClinicalTrials.gov

To request an appointment, call 844-323-1227.